November 17, 2017

Targeted Sequencing using Custom NEBNext Direct Panels

Addressing common issues in next generation sequencing assays
Have you considered incorporating genomics into your clinical trial design? In this presentation, you will explore the key attributes of genomic assays in support of clinical development.

You will also be introduced to the NEBNext Direct methodology, which addresses common issues that plague next generation sequencing (NGS) assays.

Q2 Solutions offers a comprehensive suite of genomic services to help you design and execute smarter trials. Download our presentation to learn more.

Jennifer Sims, Ph.D., Manager, Assay Development, Translational Genomics

Related Services:
Genomic Assays for Clinical Development

Identifying the right approach from a wealth of potential options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Translating Data into Insights with Bioinformatics

Genomic Know-How® for your drug development needs

Learn more about our genomic services

Read More